Global Law Firm Nixon Peabody Goes Live with Anaqua’s Comprehensive Suite of IP Management Software and Services
December 06, 2023 02:52 ET
|
Anaqua
BOSTON, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Anaqua, the leading provider of innovation and intellectual property (IP) management technology today announced that global law firm Nixon Peabody has gone...
The Akkermansia Company Found to be ‘First to File’ Patent Application to Treat Obesity Through Oral Use of the Probiotic Akkermansia
December 05, 2023 09:44 ET
|
The Akkermansia Company
The Akkermansia Company was found to be the "first to file" a patent application to treat obesity through oral use of the probiotic Akkermansia.
Checkpoint Therapeutics Strengthens Intellectual Property Protection for Cosibelimab with New U.S. Patent Issuance
December 05, 2023 08:30 ET
|
Checkpoint Therapeutics, Inc
Upcoming PDUFA goal date of January 3, 2024 U.S. patent protection for cosibelimab through at least May 2038 WALTHAM, Mass., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc....
Movi Family LLC files Motion to Dismiss Patent Infringement Case For Its Innovative Changing Pad
November 30, 2023 12:01 ET
|
Movi Family LLC
Pasadena, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Movi Family LLC (“Movi"), a family-owned baby brand, has filed a Motion to Dismiss a competitor lawsuit baldly alleging design patent and trade dress...
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD
November 30, 2023 07:00 ET
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a Canadian clinical stage...
Kane Biotech Announces Improved Third Quarter 2023 Financial Results
November 28, 2023 16:05 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2023 financial results. Third...
AIM ImmunoTech Bolsters Intellectual Property Estate for Ampligen® with Issuance of Two Key U.S. Patents
November 27, 2023 09:05 ET
|
AIM ImmunoTech Inc.
Extends certain exclusive U.S. rights to Ampligen for cancer and ME/CFS through 2039 Management discusses patent issuance and what this means in a brief video: here OCALA, Fla., Nov. 27, 2023 ...
Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent
November 27, 2023 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 – Conference Call to Follow
November 21, 2023 07:45 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI
November 14, 2023 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...